Division of Rheumatology, Shonan Kamakura General Hospital, Kamakura city, Kanagawa, Japan.
Mod Rheumatol Case Rep. 2023 Dec 29;8(1):83-85. doi: 10.1093/mrcr/rxad026.
We present the case of a 75-year-old man diagnosed with myasthenia gravis (MG) based on lower leg weakness and ptosis for the past 2 months before admission to our hospital. The patient was anti-acetylcholine receptor antibody-positive at admission. He was treated with pyridostigmine bromide and prednisolone, which improved the ptosis, but the lower leg muscle weakness remained. An additional lower leg magnetic resonance imaging examination suggested myositis. Inclusion body myositis (IBM) was diagnosed after a subsequent muscle biopsy. Although MG is often associated with inflammatory myopathy, IBM is rare. There is no effective treatment for IBM, but various treatment possibilities have recently been proposed. This case emphasises that myositis complications, including IBM, should be considered when elevated creatine kinase levels are observed and conventional treatments do not address chronic muscle weakness.
我们报告了一例 75 岁男性患者,因入院前 2 个月出现下肢无力和眼睑下垂而被诊断为重症肌无力(MG)。入院时该患者乙酰胆碱受体抗体阳性。他接受了溴吡斯的明和泼尼松龙治疗,眼睑下垂得到改善,但下肢肌无力仍存在。随后的下肢磁共振成像检查提示肌炎。随后的肌肉活检诊断为包涵体肌炎(IBM)。虽然 MG 常与炎性肌病相关,但 IBM 很少见。目前尚无有效的 IBM 治疗方法,但最近提出了多种治疗可能性。该病例强调,当出现肌酸激酶水平升高且常规治疗不能解决慢性肌肉无力时,应考虑包括 IBM 在内的肌炎并发症。